Day: September 20, 2022

IBI awarded new and extended contracts involving IBI’s Advanced Traffic Management Systems solutions TORONTO, Sept. 20, 2022 (GLOBE NEWSWIRE) —  Global design and technology firm, IBI Group Inc. (TSX: IBG) (“IBI” or the “Company”), has recently been awarded a new statewide contract and contract extension with the Florida Department of Transportation for its Advanced Traffic Management Systems (ATMS) portfolio. The contracts are expected to improve the State’s ability to manage transportation networks and improve traveller safety and ease of travel. The continuation of work with the Florida Department of Transportation will allow IBI to build upon its working relationship and offer improved, intelligent solutions based on a history of working knowledge. IBI’s new contract with the Florida Department of Transportation (FDOT) includes...

Pursuant to section 38 of the Danish Capital Markets Act, FirstFams A/S hereby announces to have received information from Henrik Hougaard, that he through his ownership of Thoraso Aps, Thoraso Holding ApS and private now owns between 15 and 19.99 percent of the shares in FirstFarms A/S. Best regards,FirstFarms A/S For further information:Please visit our website www.firstfarms.com or contact CEO Anders H. Nørgaard on phone +45 75 86 87 87. About FirstFarms:FirstFarms is a Danish stock exchange listed company. We operate FirstFarms with responsibility for the surrounding communities, and we deliver highest quality which is primarily sold locally. We act on new opportunities, that create value for our investors and for the surroundings. Every day, we work on creating a more sustainable company.Attachment(20) Major shareholder...

The Extraordinary General Meeting of Norsk Hydro ASA was held on September 20, 2022. All proposals on the agenda were adopted, including the proposal to distribute an additional dividend of NOK 1.45 per share. The dividend will be paid on September 30, 2022, to shareholders as of September 20, 2022, and who are listed in the Norwegian Central Securities Depository as of September 22, 2022. The share will be traded ex-dividend from September 21, 2022. The minutes of the Extraordinary General Meeting are attached and also available on www.hydro.com/generalmeeting. Investor contact: Line Haugetraa +47 41406376 Line.Haugetraa@hydro.comThis information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentNorsk Hydro ASA – Minutes from Extraordinary General...

VANCOUVER, British Columbia, Sept. 20, 2022 (GLOBE NEWSWIRE) — Arctic Fox Minerals Corp. (CSE: FOXY) (the “Company” or “Arctic Fox”) is pleased to announce the appointment of Robert Gietl as the new Chief Executive Officer (“CEO”) of the Company effective September 15, 2022. Mr. Gietl brings extensive executive management and business development experience to the Company. He is an experienced business leader with a proven track record of implementing organizational change including through entry into new markets, fiscal accountability, and business plan execution. He has increased business performance in a wide variety of sectors across Canada and has worked diligently to align stakeholders’ goals and values. Dixon Lawson has stepped down from his duties as CEO. Management and Directors of Arctic Fox would like to take this opportunity...

COPENHAGEN, Denmark, September 20, 2022 – Bavarian Nordic A/S (OMX: BAVA) announced today that the board of directors has appointed Luc Debruyne as an observer to the board with the intent to nominate him for election to the board at the ordinary general meeting in March 2023, where he following the board’s constitution is expected to assume the chairmanship after Gerard van Odijk, who will step down after having served for 15 years on the board. Luc Debruyne is former President Global Vaccines at GSK, a role he held for the last six years of his 27-year long tenure with the company, where he was a member of GSK’s Corporate Executive Team. He is currently Professor of Practice at the University of Leuven, Faculty of Medicine, Biomedical Sciences Group and serves as non-executive director of the boards of University Hospitals UZ Leuven...

Prestigious Honor Supports Increasing Interest in Broad Clinical Benefits of Synthetic Products in Wound Healing FRAMINGHAM, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) — Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical products, today announced that AC5® Advanced Wound System (“AC5”) was selected for the “Innovation Spotlight: Shining a Light on Bold Ideas in Wound Care” session at the 2022 Symposium on Advanced Wound Care (“SAWC”). The prestigious honor represents the Company’s second consecutive Innovation Spotlight acceptance. The session is being held at Caesars Palace, Las Vegas, Nevada on October 16, 2022, between 11:20 AM to 12:20 PM PT during the SAWC Annual Conference. AC5 is a novel self-assembling wound care product and is the first...

The project will supply up to 25% of US copper needs, helping to secure a clean energy future EDMONTON, Alberta and NEW YORK, Sept. 20, 2022 (GLOBE NEWSWIRE) — TSX, NYSE:STN Stantec, a global leader in sustainable design and engineering, has been selected by Resolution Copper Mining LLC (Resolution Copper) to deliver a US$16 million feasibility study providing engineering and technical services for the Resolution Copper mine in Superior, Arizona. The proposed underground mine has the potential to be one of the largest producers of copper in North America—supplying up to 25% of US copper demand each year. Copper from the mine will be used in products that are vital to the energy transition, such as electric vehicles, batteries, solar panels, wind turbines, and more. Resolution Copper is a limited liability company that is owned...

BOSTON and GENEVA, Switzerland, Sept. 20, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, will host its first-ever Investor Day TODAY in-person at PUBLIC Hotel in New York City. The event will begin at 1:30 p.m. EDT and is expected to conclude at approximately 5:30 p.m. EDT. Presenters include:Troy Cox, Chairman of the board Dr. Jurgi Camblong, Chief Executive Officer and co-founder Ken Freedman, Chief Revenue Officer Peter Casasanto, Chief BioPharma Officer Dr. Philippe Menu, Chief Medical Officer Abhi Verma, Chief Technology Officer Dr. Zhenyu Xu, Chief Scientific Officer Ross Muken, Chief Financial OfficerToday’s Investor Day will offer an opportunity for investors to learn from the company’s executive team about its key differentiators and strategies that...